"Responsabilité - Humanisme - Excellence"

During the past decade, Polyclinique Bordeaux Nord Aquitaine conducted 75 clinical trials. In the 10-year time frame, 75 clinical trials started and 13 clinical trials were completed, i.e. on average, 17.3% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 8 clinical trials were completed. i.e. 27.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Polyclinique Bordeaux Nord Aquitaine" #1 sponsor was "The Lymphoma Academic Research Organisation" with 14 trials, followed by "Federation Francophone de Cancerologie Digestive" with 9 trials sponsored, "Hoffmann-La Roche" with 9 trials sponsored, "UNICANCER" with 9 trials sponsored and "Intergroupe Francophone de Cancerologie Thoracique" with 9 trials sponsored. Other sponsors include 81 different institutions and companies that sponsored additional 55 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinique Bordeaux Nord Aquitaine" #1 collaborator was "AstraZeneca" with 5 trials as a collaborator, "Pfizer" with 4 trials as a collaborator, "Amgen" with 3 trials as a collaborator, "Breast International Group" with 3 trials as a collaborator and "Intergroupe Francophone du Myelome" with 3 trials as a collaborator. Other collaborators include 85 different institutions and companies that were collaborators in the rest 85 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinique Bordeaux Nord Aquitaine" are "Breast Cancer" (12 trials), "Multiple Myeloma" (9 trials), "Follicular Lymphoma" (7 trials), "Colorectal Cancer" (6 trials) and "Ovarian Cancer" (5 trials). Many other conditions were trialed in "Polyclinique Bordeaux Nord Aquitaine" in a lesser frequency.

Most popular intervention types in "Polyclinique Bordeaux Nord Aquitaine" are "Drug" (98 trials), "Procedure" (12 trials), "Device" (10 trials), "Other" (10 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Paclitaxel" (9 trials), "Lenalidomide" (7 trials), "Bevacizumab" (6 trials) and "Carboplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique Bordeaux Nord Aquitaine" are 113 trials for "All" genders and 22 trials for "Female" genders.

Currently, there are NaN active trials in "Polyclinique Bordeaux Nord Aquitaine". 1 are not yet recruiting, 25 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 73 completed trials in Polyclinique Bordeaux Nord Aquitaine, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique Bordeaux Nord Aquitaine, 1 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 19 trials that are defined as “Not Applicable".

Polyclinique Bordeaux Nord Aquitaine has several departments that took part in Clinical trials: "Polyclin Bordeaux Nord Aquitaine; Gastro Enterologie" - 2 trials